Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty
M.S. in Bioethics Program Director Dr. Robert Klitzman speaks on the ethics of Dr. Craig Towers’ research and the importance of informed consent.
(ProPublica)
Faculty
Our world depends on practical, systems-level solutions that support a more sustainable, circular, and climate-resilient future.
Faculty
Columbia’s M.S. in Applied Analytics community came together at Ai4, one of the largest AI conferences in North America to present to and learn from the best in the field.
All News
